Click to scroll back to the top
Share on FacebookShare on TwitterShare on Linkedin
Follow us
Copyright 2024. Houston Methodist, Houston, TX. All rights reserved.
Click to go to previous articleClick to go to next article
Close.svg
result
Precision Medicine
dM_Covid_Vaccines_Variants_thumb.jpg
Variants, Vaccines and Vigilance
An updated look at circulating SARS-CoV-2 variants, with a dose of more effective vaccine booster scheduling, tailored by Houston Methodist researchers applying Mathematics in Medicine.
Read now
Blue small right arrow picture
dM_aortic_morphology_thumb.jpg
Precise measurements of the aortic morphologies are crucial for optimal endograft sizing
A retrospective study at Houston Methodist has identified the area of the aorta as the most important parameter to measure for endograft sizing to treat ascending thoracic aorta pathologies.
Read now
Blue small right arrow picture
dM_RNA_Therapeutics_Thumb_Image.jpg
Read now
Blue small right arrow picture
RNA therapeutics have the potential to transform standard patient care and actualize personalized medicine
RNA as a therapeutic molecule holds great power and the potential to alter the standard of care for patients, actualize personalized medicine, and have diverse applications.
New theranostic shows promise for treating triple-negative breast cancer
The radiolabeled 64Cu/177Lu-DOTA-diZD small synthetic molecule revolutionizes treatment strategies for primary and metastatic tumors in aggressive triple-negative breast cancer by targeting angiogenic receptors.
Read now
Interleukin 9 secreting polarized T cells show potential in solid and liquid tumor treatment
A cancer patient’s T cells, engineered to carry a receptor found on the surface of malignant cells, can aggressively attack tumors - with the potential to revolutionize solid tumor treatment.
Read now
carfilzomibtherapy_thumb.jpg
Carfilzomib therapy may enhance longevity in lung transplant recipients
Carfilzomib therapy shows potential in improving patient outcomes and longevity.
Read now
Share this story
Facebook.svgTwitter.svgLinkedin.svg